ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global End Stage Renal Disease Treatment Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-2F6212
Home | Market Reports | Health| Health Conditions
Global End Stage Renal Disease Treatment Market Research Report 2022
BUY CHAPTERS

Global End Stage Renal Disease Treatment Market Research Report 2025

Code: QYRE-Auto-2F6212
Report
March 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
NIKKISO
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Sanxin Medtec

End Stage Renal Disease Treatment Market Size

The global market for End Stage Renal Disease Treatment was valued at US$ 58050 million in the year 2024 and is projected to reach a revised size of US$ 83790 million by 2031, growing at a CAGR of 5.5% during the forecast period.

End Stage Renal Disease Treatment Market

End Stage Renal Disease Treatment Market

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report aims to provide a comprehensive presentation of the global market for End Stage Renal Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End Stage Renal Disease Treatment.
The End Stage Renal Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global End Stage Renal Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the End Stage Renal Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of End Stage Renal Disease Treatment Market Report

Report Metric Details
Report Name End Stage Renal Disease Treatment Market
Accounted market size in year US$ 58050 million
Forecasted market size in 2031 US$ 83790 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hemodialysis
  • Peritoneal Dialysis
  • Kidney Transplantation
Segment by Application
  • Hospitals
  • Kidney Dialysis Centers
  • At Homes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of End Stage Renal Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is End Stage Renal Disease Treatment Market growing?

Ans: The End Stage Renal Disease Treatment Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the End Stage Renal Disease Treatment Market size in 2031?

Ans: The End Stage Renal Disease Treatment Market size in 2031 will be US$ 83790 million.

What is the Fresenius, DaVita, Baxter share in End Stage Renal Disease Treatment Market?

Ans: Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc.

What is the End Stage Renal Disease Treatment Market share by type?

Ans: In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.

Who are the main players in the End Stage Renal Disease Treatment Market report?

Ans: The main players in the End Stage Renal Disease Treatment Market are Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical

What are the Application segmentation covered in the End Stage Renal Disease Treatment Market report?

Ans: The Applications covered in the End Stage Renal Disease Treatment Market report are Hospitals, Kidney Dialysis Centers, At Homes, Others

What are the Type segmentation covered in the End Stage Renal Disease Treatment Market report?

Ans: The Types covered in the End Stage Renal Disease Treatment Market report are Hemodialysis, Peritoneal Dialysis, Kidney Transplantation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End Stage Renal Disease Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hemodialysis
1.2.3 Peritoneal Dialysis
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global End Stage Renal Disease Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global End Stage Renal Disease Treatment Market Perspective (2020-2031)
2.2 Global End Stage Renal Disease Treatment Growth Trends by Region
2.2.1 Global End Stage Renal Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 End Stage Renal Disease Treatment Historic Market Size by Region (2020-2025)
2.2.3 End Stage Renal Disease Treatment Forecasted Market Size by Region (2026-2031)
2.3 End Stage Renal Disease Treatment Market Dynamics
2.3.1 End Stage Renal Disease Treatment Industry Trends
2.3.2 End Stage Renal Disease Treatment Market Drivers
2.3.3 End Stage Renal Disease Treatment Market Challenges
2.3.4 End Stage Renal Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top End Stage Renal Disease Treatment Players by Revenue
3.1.1 Global Top End Stage Renal Disease Treatment Players by Revenue (2020-2025)
3.1.2 Global End Stage Renal Disease Treatment Revenue Market Share by Players (2020-2025)
3.2 Global End Stage Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by End Stage Renal Disease Treatment Revenue
3.4 Global End Stage Renal Disease Treatment Market Concentration Ratio
3.4.1 Global End Stage Renal Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease Treatment Revenue in 2024
3.5 Global Key Players of End Stage Renal Disease Treatment Head office and Area Served
3.6 Global Key Players of End Stage Renal Disease Treatment, Product and Application
3.7 Global Key Players of End Stage Renal Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 End Stage Renal Disease Treatment Breakdown Data by Type
4.1 Global End Stage Renal Disease Treatment Historic Market Size by Type (2020-2025)
4.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2026-2031)
5 End Stage Renal Disease Treatment Breakdown Data by Application
5.1 Global End Stage Renal Disease Treatment Historic Market Size by Application (2020-2025)
5.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America End Stage Renal Disease Treatment Market Size (2020-2031)
6.2 North America End Stage Renal Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America End Stage Renal Disease Treatment Market Size by Country (2020-2025)
6.4 North America End Stage Renal Disease Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe End Stage Renal Disease Treatment Market Size (2020-2031)
7.2 Europe End Stage Renal Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe End Stage Renal Disease Treatment Market Size by Country (2020-2025)
7.4 Europe End Stage Renal Disease Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific End Stage Renal Disease Treatment Market Size (2020-2031)
8.2 Asia-Pacific End Stage Renal Disease Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America End Stage Renal Disease Treatment Market Size (2020-2031)
9.2 Latin America End Stage Renal Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America End Stage Renal Disease Treatment Market Size by Country (2020-2025)
9.4 Latin America End Stage Renal Disease Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa End Stage Renal Disease Treatment Market Size (2020-2031)
10.2 Middle East & Africa End Stage Renal Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Details
11.1.2 Fresenius Business Overview
11.1.3 Fresenius End Stage Renal Disease Treatment Introduction
11.1.4 Fresenius Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Details
11.2.2 DaVita Business Overview
11.2.3 DaVita End Stage Renal Disease Treatment Introduction
11.2.4 DaVita Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter End Stage Renal Disease Treatment Introduction
11.3.4 Baxter Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Details
11.4.2 Nipro Business Overview
11.4.3 Nipro End Stage Renal Disease Treatment Introduction
11.4.4 Nipro Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun End Stage Renal Disease Treatment Introduction
11.5.4 B. Braun Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Details
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei End Stage Renal Disease Treatment Introduction
11.6.4 Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Details
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso End Stage Renal Disease Treatment Introduction
11.7.4 Nikkiso Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Details
11.8.2 WEGO Business Overview
11.8.3 WEGO End Stage Renal Disease Treatment Introduction
11.8.4 WEGO Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Details
11.9.2 Newsol Business Overview
11.9.3 Newsol End Stage Renal Disease Treatment Introduction
11.9.4 Newsol Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic End Stage Renal Disease Treatment Introduction
11.10.4 Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Details
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight End Stage Renal Disease Treatment Introduction
11.11.4 Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Details
11.12.2 Medtronic Business Overview
11.12.3 Medtronic End Stage Renal Disease Treatment Introduction
11.12.4 Medtronic Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Details
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec End Stage Renal Disease Treatment Introduction
11.13.4 Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Details
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical End Stage Renal Disease Treatment Introduction
11.14.4 Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Details
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Details
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical End Stage Renal Disease Treatment Introduction
11.16.4 Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (2020-2025)
11.16.5 Tianyi Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Medtronic Inc
NIKKISO
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Sanxin Medtec
List of Tables
 Table 1. Global End Stage Renal Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hemodialysis
 Table 3. Key Players of Peritoneal Dialysis
 Table 4. Key Players of Kidney Transplantation
 Table 5. Global End Stage Renal Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global End Stage Renal Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global End Stage Renal Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global End Stage Renal Disease Treatment Market Share by Region (2020-2025)
 Table 9. Global End Stage Renal Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global End Stage Renal Disease Treatment Market Share by Region (2026-2031)
 Table 11. End Stage Renal Disease Treatment Market Trends
 Table 12. End Stage Renal Disease Treatment Market Drivers
 Table 13. End Stage Renal Disease Treatment Market Challenges
 Table 14. End Stage Renal Disease Treatment Market Restraints
 Table 15. Global End Stage Renal Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global End Stage Renal Disease Treatment Market Share by Players (2020-2025)
 Table 17. Global Top End Stage Renal Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Treatment as of 2024)
 Table 18. Ranking of Global Top End Stage Renal Disease Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by End Stage Renal Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of End Stage Renal Disease Treatment, Headquarters and Area Served
 Table 21. Global Key Players of End Stage Renal Disease Treatment, Product and Application
 Table 22. Global Key Players of End Stage Renal Disease Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global End Stage Renal Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global End Stage Renal Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America End Stage Renal Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America End Stage Renal Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe End Stage Renal Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe End Stage Renal Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific End Stage Renal Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America End Stage Renal Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America End Stage Renal Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Fresenius Company Details
 Table 48. Fresenius Business Overview
 Table 49. Fresenius End Stage Renal Disease Treatment Product
 Table 50. Fresenius Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 51. Fresenius Recent Development
 Table 52. DaVita Company Details
 Table 53. DaVita Business Overview
 Table 54. DaVita End Stage Renal Disease Treatment Product
 Table 55. DaVita Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 56. DaVita Recent Development
 Table 57. Baxter Company Details
 Table 58. Baxter Business Overview
 Table 59. Baxter End Stage Renal Disease Treatment Product
 Table 60. Baxter Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 61. Baxter Recent Development
 Table 62. Nipro Company Details
 Table 63. Nipro Business Overview
 Table 64. Nipro End Stage Renal Disease Treatment Product
 Table 65. Nipro Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 66. Nipro Recent Development
 Table 67. B. Braun Company Details
 Table 68. B. Braun Business Overview
 Table 69. B. Braun End Stage Renal Disease Treatment Product
 Table 70. B. Braun Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 71. B. Braun Recent Development
 Table 72. Asahi Kasei Company Details
 Table 73. Asahi Kasei Business Overview
 Table 74. Asahi Kasei End Stage Renal Disease Treatment Product
 Table 75. Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 76. Asahi Kasei Recent Development
 Table 77. Nikkiso Company Details
 Table 78. Nikkiso Business Overview
 Table 79. Nikkiso End Stage Renal Disease Treatment Product
 Table 80. Nikkiso Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 81. Nikkiso Recent Development
 Table 82. WEGO Company Details
 Table 83. WEGO Business Overview
 Table 84. WEGO End Stage Renal Disease Treatment Product
 Table 85. WEGO Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 86. WEGO Recent Development
 Table 87. Newsol Company Details
 Table 88. Newsol Business Overview
 Table 89. Newsol End Stage Renal Disease Treatment Product
 Table 90. Newsol Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 91. Newsol Recent Development
 Table 92. Mayo Clinic Company Details
 Table 93. Mayo Clinic Business Overview
 Table 94. Mayo Clinic End Stage Renal Disease Treatment Product
 Table 95. Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 96. Mayo Clinic Recent Development
 Table 97. Guangdong Biolight Company Details
 Table 98. Guangdong Biolight Business Overview
 Table 99. Guangdong Biolight End Stage Renal Disease Treatment Product
 Table 100. Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 101. Guangdong Biolight Recent Development
 Table 102. Medtronic Company Details
 Table 103. Medtronic Business Overview
 Table 104. Medtronic End Stage Renal Disease Treatment Product
 Table 105. Medtronic Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 106. Medtronic Recent Development
 Table 107. Sanxin Medtec Company Details
 Table 108. Sanxin Medtec Business Overview
 Table 109. Sanxin Medtec End Stage Renal Disease Treatment Product
 Table 110. Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 111. Sanxin Medtec Recent Development
 Table 112. Jafron Biomedical Company Details
 Table 113. Jafron Biomedical Business Overview
 Table 114. Jafron Biomedical End Stage Renal Disease Treatment Product
 Table 115. Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 116. Jafron Biomedical Recent Development
 Table 117. SWS Hemodialysis Care Company Details
 Table 118. SWS Hemodialysis Care Business Overview
 Table 119. SWS Hemodialysis Care End Stage Renal Disease Treatment Product
 Table 120. SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 121. SWS Hemodialysis Care Recent Development
 Table 122. Tianyi Medical Company Details
 Table 123. Tianyi Medical Business Overview
 Table 124. Tianyi Medical End Stage Renal Disease Treatment Product
 Table 125. Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (2020-2025) & (US$ Million)
 Table 126. Tianyi Medical Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. End Stage Renal Disease Treatment Picture
 Figure 2. Global End Stage Renal Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global End Stage Renal Disease Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Hemodialysis Features
 Figure 5. Peritoneal Dialysis Features
 Figure 6. Kidney Transplantation Features
 Figure 7. Global End Stage Renal Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global End Stage Renal Disease Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Kidney Dialysis Centers Case Studies
 Figure 11. At Homes Case Studies
 Figure 12. Others Case Studies
 Figure 13. End Stage Renal Disease Treatment Report Years Considered
 Figure 14. Global End Stage Renal Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global End Stage Renal Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global End Stage Renal Disease Treatment Market Share by Region: 2024 VS 2031
 Figure 17. Global End Stage Renal Disease Treatment Market Share by Players in 2024
 Figure 18. Global Top End Stage Renal Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Treatment as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by End Stage Renal Disease Treatment Revenue in 2024
 Figure 20. North America End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America End Stage Renal Disease Treatment Market Share by Country (2020-2031)
 Figure 22. United States End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe End Stage Renal Disease Treatment Market Share by Country (2020-2031)
 Figure 26. Germany End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific End Stage Renal Disease Treatment Market Share by Region (2020-2031)
 Figure 34. China End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America End Stage Renal Disease Treatment Market Share by Country (2020-2031)
 Figure 42. Mexico End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa End Stage Renal Disease Treatment Market Share by Country (2020-2031)
 Figure 46. Turkey End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE End Stage Renal Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Fresenius Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 50. DaVita Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 51. Baxter Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 52. Nipro Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 53. B. Braun Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 54. Asahi Kasei Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 55. Nikkiso Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 56. WEGO Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 57. Newsol Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 58. Mayo Clinic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 59. Guangdong Biolight Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 60. Medtronic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 61. Sanxin Medtec Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 62. Jafron Biomedical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 63. SWS Hemodialysis Care Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 64. Tianyi Medical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Insulin Glargine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-2316
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Bilirubin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-35U2436
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Intracardiac Echocardiography Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7J13314
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global End Stage Renal Disease Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2F6212
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions